Gate2Brain semifinalist of EITHealth’s Catapult 2022

EITHealth Catapult 2022eithealth

We’re proud to share that Gate2Brain is semifinalist of EITHealth‘s Catapult 2022.

Thanks to this programme we will pitch our solution to experts and industry leaders for the opportunity to receive funding to catapult our start-up to success.

Catapult showcases the best business concepts from medtech, biotech and digital health to leading experts and investors. Their programme offers intensive training and fierce competition and gives start-ups the support they need to be investment-ready and succeed:  eithealth.eu/programmes/catapult

/by
You might also like
Gate2Brain among the 5 Catalan startups that have obtained funding from EIC AcceleratorcanvaGate2Brain among the 5 Catalan startups that have obtained funding from EIC Accelerator
Three University of Barcelona spin-offs led by women will receive funding as part of the Women TechEU pilot callFundació Bosch i GimperaThree University of Barcelona spin-offs receive funding from Women TechEU
ACCIOGate2Brain considered one of the most relevants startups in Catalonia Startup Hub
Grit International Female Accelerator!Grit International Female AcceleratorG2B joined the Grit International Female Accelerator
la start-up catalana una de las ganadoras del South Summit de salud en Valenciala VanguardiaGate2Brain one of the winners of the South Summit Health & Well-being
Gate2Brain among the 20 BioTech Startups to Watch in 2024
Nadia Calviño, First Vice President of the Government and Minister of Economic Affairs visits Gate2BrainSJDNadia Calviño, First Vice President of the Government visits Gate2Brain
Innovation & Scalability for the new generationsInnovation & Scalability for the new generations
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

Exploration Science with Dr. Wendy HarsockWithin the framework of the discussion-based interview series, Exploration Science, in which scientists talk about their ventures and areas of expertise, our CEO, Dr. Meritxell Teixidó, and the first and only APS American Peptide Idol joined @CEM's Dr. Wendy Hartsock to discuss the work @Gate2Brain is doing in pediatric oncology, dive into the technology, and talk about empathetic leadership and the power of diversity.CEMmedicines beyond barriersG2BMedicines beyond barriers